Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOBAPLATIN vs LOMITAPIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOBAPLATIN vs LOMITAPIDE: Safety Overview

Metric LOBAPLATIN LOMITAPIDE
Total FAERS Reports 199 3,779
Deaths Reported 8 109
Death Rate 4.0% 2.9%
Hospitalizations 88 434
Average Patient Age 57.6 yrs 54.6 yrs
% Female Patients 65.5% 66.5%
FDA Approval Date N/A Apr 23, 2015
Manufacturer N/A Amryt Pharmaceuticals DAC
Route N/A ORAL
Marketing Status N/A Prescription